BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19350681)

  • 1. Molecular characterization of the human NANOG protein.
    Chang DF; Tsai SC; Wang XC; Xia P; Senadheera D; Lutzko C
    Stem Cells; 2009 Apr; 27(4):812-21. PubMed ID: 19350681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a putative transactivation domain in human Nanog.
    Oh JH; Do HJ; Yang HM; Moon SY; Cha KY; Chung HM; Kim JH
    Exp Mol Med; 2005 Jun; 37(3):250-4. PubMed ID: 16000880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a putative nuclear export signal motif in human NANOG homeobox domain.
    Park SW; Do HJ; Huh SH; Sung B; Uhm SJ; Song H; Kim NH; Kim JH
    Biochem Biophys Res Commun; 2012 May; 421(3):484-9. PubMed ID: 22516749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.
    Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two potent transactivation domains in the C-terminal region of human NANOG mediate transcriptional activation in human embryonic carcinoma cells.
    Do HJ; Lee WY; Lim HY; Oh JH; Kim DK; Kim JH; Kim T; Kim JH
    J Cell Biochem; 2009 Apr; 106(6):1079-89. PubMed ID: 19229867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog.
    Pan GJ; Pei DQ
    Cell Res; 2003 Dec; 13(6):499-502. PubMed ID: 14728807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intact homeobox domain is required for complete nuclear localization of human Nanog.
    Do HJ; Lim HY; Kim JH; Song H; Chung HM; Kim JH
    Biochem Biophys Res Commun; 2007 Feb; 353(3):770-5. PubMed ID: 17196939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of an alternative splice variant within the fourth exon of human nanog.
    Kim JS; Kim J; Kim BS; Chung HY; Lee YY; Park CS; Lee YS; Lee YH; Chung IY
    Exp Mol Med; 2005 Dec; 37(6):601-7. PubMed ID: 16391521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus.
    Pan G; Pei D
    J Biol Chem; 2005 Jan; 280(2):1401-7. PubMed ID: 15502159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal pentapeptide of Nanog tryptophan repeat domain interacts with Nac1 and regulates stem cell proliferation but not pluripotency.
    Ma T; Wang Z; Guo Y; Pei D
    J Biol Chem; 2009 Jun; 284(24):16071-16081. PubMed ID: 19366700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and functional evaluation of porcine NANOG that is a single-exon gene and has two pseudogenes.
    Yang F; Zhang J; Liu Y; Cheng D; Wang H
    Int J Biochem Cell Biol; 2015 Feb; 59():142-52. PubMed ID: 25542179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.
    Chan KK; Zhang J; Chia NY; Chan YS; Sim HS; Tan KS; Oh SK; Ng HH; Choo AB
    Stem Cells; 2009 Sep; 27(9):2114-25. PubMed ID: 19522013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells.
    Park SW; Lim HY; Do HJ; Sung B; Huh SH; Uhm SJ; Song H; Chung HJ; Kim JH; Kim NH; Kim JH
    FEBS Lett; 2012 Sep; 586(19):3529-35. PubMed ID: 22963770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter.
    Wu DY; Yao Z
    Cell Res; 2006 Mar; 16(3):319-22. PubMed ID: 16541131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanog and transcriptional networks in embryonic stem cell pluripotency.
    Pan G; Thomson JA
    Cell Res; 2007 Jan; 17(1):42-9. PubMed ID: 17211451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal.
    Pereira L; Yi F; Merrill BJ
    Mol Cell Biol; 2006 Oct; 26(20):7479-91. PubMed ID: 16894029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3.
    Torres J; Watt FM
    Nat Cell Biol; 2008 Feb; 10(2):194-201. PubMed ID: 18223644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog.
    Jauch R; Ng CK; Saikatendu KS; Stevens RC; Kolatkar PR
    J Mol Biol; 2008 Feb; 376(3):758-70. PubMed ID: 18177668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene.
    Lu M; Miller C; Habener JF
    Endocrinology; 1996 Jul; 137(7):2959-67. PubMed ID: 8770920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional repressor Nkx6.1 also functions as a deoxyribonucleic acid context-dependent transcriptional activator during pancreatic beta-cell differentiation: evidence for feedback activation of the nkx6.1 gene by Nkx6.1.
    Iype T; Taylor DG; Ziesmann SM; Garmey JC; Watada H; Mirmira RG
    Mol Endocrinol; 2004 Jun; 18(6):1363-75. PubMed ID: 15056733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.